NCT05482191

Brief Summary

Childhood obesity is a significant public health concern worldwide. In China, childhood obesity has dramatically increased as the economy has grown quickly over the past decades. Nonalcoholic fatty liver disease (NAFLD) is tightly associated with obesity, in China, the prevalence of NAFLD in obesity children is 40.0%,the main interventions for NAFLD are lifestyle interventions. Effective strategies to helping students lose weight and alleviate NAFLD through lifestyle interventions may help promote the physical and mental health of obese students. This study aimed (1)to assess the effectiveness of the intervention compared with the usual practice in treating childhood overweight and obesity; (2) to determine the sustainability of the treatment in preventing overweight and obesity; (3) to help alleviate or reverse NAFLD in obesity children. Children with overweight and obesity in six primary schools in Ningbo City, Zhejiang Province will be seleted and randomly divided into two groups: the treatment group and the usual practice group. The participants of the study were students in the third grade of primary school, and the treatment will last for one academic year. This treatment activity on lifestyle interventions will target the dietary and exercise factors of childhood obesity.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
331

participants targeted

Target at P75+ for not_applicable obesity

Timeline
Completed

Started Sep 2022

Typical duration for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 1, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 25, 2023

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

July 9, 2025

Status Verified

July 1, 2025

Enrollment Period

10 months

First QC Date

July 28, 2022

Last Update Submit

July 4, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • change in body mass index (BMI)

    * weight and height will be combined to report BMI in kg/m\^2 * caculated by terminal value minus baseline value

    3 months,9 months , 24 months and 36 months

  • change in controlled attenuation parameters (CAP)

    * CAP will be detected by Fibroscan * caculated by terminal value minus baseline value

    3 months,9 months , 24 months and 36 months

  • Change in liver stiffness measurement (LSM)

    * LSM will be detected by Fibroscan * caculated by terminal value minus baseline value

    3 months,9 months , 24 months and 36 months

Secondary Outcomes (9)

  • Change in BMI z- score

    3 months,9 months , 24 months and 36 months

  • change in blood glucose

    9 months

  • change in blood lipids

    9 months

  • change in fasting insulin

    9 months

  • change in body fat percentage

    3 months and 9 months

  • +4 more secondary outcomes

Study Arms (2)

Treatment group

EXPERIMENTAL

Treatment activity on lifestyle interventions will target the dietary and exercise factors of childhood obesity.

Behavioral: Lifestyle intervention

Usual practice group

NO INTERVENTION

No intervention

Interventions

This intervention programme will target the influencing factors of childhood obesity to influence the knowledge, attitude and behaviours of school children. Students in the treatment group will receive the following interventions: * Develop and implement school policies related to weight loss * Distribute health education materials on diet and exercise to students * Carry out student health education courses * Diet and exercise instruction by professional nutritionist using internet applet * Take part in sports activities that are organized by the sports health teacher during school hours.

Treatment group

Eligibility Criteria

Age8 Years - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • parents agree and support their children's weight loss, and students and parents have informed consent;
  • students in third grade aged 8 and 10 years old;
  • students with childhood overweight/obesity defined according to the criteria for Chinese children and adolescents.

You may not qualify if:

  • medical history of heart disease, hypertension, diabetes, tuberculosis, asthma, hepatitis or nephritis;
  • obesity caused by endocrine diseases or side effects of drugs;
  • abnormal physical development like dwarfism or gigantism;
  • physical deformity such as severe scoliosis, pectus carinatum, limp, obvious O-leg or X-leg;
  • inability to participate in school sport activities;
  • a loss in weight by vomiting or taking drugs during the past 3 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ningbo First Hospital

Ningbo, China

Location

Related Publications (1)

  • Zhang PP, Wang YX, Shen FJ, Xing YF, Gu JY, Li XY, Jin H, Jin SF, Xu M, Wang HJ, Wang H, Li L. Lifestyle intervention in children with obesity and nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled trial in Ningbo city (the SCIENT study). Trials. 2024 Mar 20;25(1):196. doi: 10.1186/s13063-024-08046-4.

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2022

First Posted

August 1, 2022

Study Start

September 1, 2022

Primary Completion

June 25, 2023

Study Completion

December 31, 2025

Last Updated

July 9, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations